Director/PDMR Shareholding

Summary by AI BETAClose X

CT Healthcare Trust Plc announced that Director Sarah MacAulay purchased 36,000 Redeemable Ordinary Shares on April 13, 2026, on the London Stock Exchange for a total of £50,076, at a price of 139.1 pence per share. Following this transaction, Ms. MacAulay now holds a total of 66,000 shares in the company.

Disclaimer*

CT Healthcare Trust PLC
16 April 2026
 

CT HEALTHCARE TRUST plc

 

LEI: 213800HQ3J3H9YF2UI82

Director dealings

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Sarah MacAulay

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

CT Healthcare Trust Plc

b)

 

LEI

 

 

 

213800HQ3J3H9YF2UI82

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Redeemable Ordinary Shares



Identification code

ISIN

GB00BZCNLL95




b)

 

Nature of the transaction

Purchase of shares

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)


Transaction (purchase)

 

 


139.1p per share

 

36,000

 

 







d)

 

Aggregated information




- Aggregated volume

Purchase: 36,000



- Price

Total price: £50,076



e)

 

Date of the transaction

 

 

 13 April 2026

f)

 

Place of the transaction

 

 

London Stock Exchange

Sarah MacAulay holds 66,000 shares in the Company.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings